Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Erectile dysfunction].

R Andrianne1, Y Kallel

  • 1Service d'Urologie, CHU Sart Tilman, Liège.

Revue Medicale De Liege
|July 23, 2005
PubMed
Summary
This summary is machine-generated.

Diabetes frequently causes erectile dysfunction (ED), with diabetics experiencing ED three times more often than the general population. Phosphodiesterase type 5 inhibitors are the primary treatment for this condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictive factors of bowel necrosis in patients with incarcerated femoral hernia.

Hernia : the journal of hernias and abdominal wall surgery·2023
Same author

Analysis of the effects of different surgical approaches on corporotomy localization in inflatable penile implant surgery performed by expert implant surgeons.

International journal of impotence research·2022
Same author

[Medium-term results of internal urinary diversion via sigmoido-rectal Mainz II pouch in case of irreparable vesico-vaginal obstetric fistula in Ouagadougou].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2022
Same author

[Metastase from lobular breast carcinoma on the ileal patch of augmentation].

Revue medicale de Liege·2020
Same author

The "Mini-Jupette" sling at the time of inflatable penile prosthesis implantation: Adequate treatment for erectile dysfunction with mild incontinence and/or climacturia after radical prostatectomy.

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2019
Same author

[Cystic nephroma : a rare kidney neoplasm].

Revue medicale de Liege·2019
Same journal

[Nature prescriptions and health promotion : sharing experience from primary care].

Revue medicale de Liege·2026
Same journal

[Eco-health: shared perspectives on primary care practice].

Revue medicale de Liege·2026
Same journal

[The strategic role of primary care in emerging diseases : surveillance, research, and preparedness].

Revue medicale de Liege·2026
Same journal

[Environmental impact of medicines and approaches for more eco responsible use].

Revue medicale de Liege·2026
Same journal

[Climate change and skin].

Revue medicale de Liege·2026
Same journal

[From Silent Spring to neuronal silence : pesticides and neurodegenerative diseases].

Revue medicale de Liege·2026
See all related articles

Area of Science:

  • Endocrinology
  • Urology
  • Diabetology

Context:

  • Erectile dysfunction (ED) is a common complication in patients with diabetes mellitus.
  • Diabetic ED prevalence is significantly higher (3x) compared to the non-diabetic population.
  • The etiology of ED in diabetic individuals is multifactorial, involving vascular, neurological, and hormonal pathways.

Purpose:

  • To highlight the strong association between diabetes and erectile dysfunction.
  • To underscore the increased prevalence of ED in diabetic patients.
  • To identify the first-line treatment for erectile dysfunction in the context of diabetes.

Summary:

  • Diabetes mellitus is a leading cause of erectile dysfunction.
  • The condition affects diabetic individuals at a substantially higher rate.

Related Experiment Videos

  • Phosphodiesterase type 5 inhibitors are established as the primary therapeutic option.

    • Impact:

    • Increased awareness of ED as a significant diabetic complication.
    • Guidance on prioritizing treatment strategies for diabetic patients with ED.
    • Potential for improved patient outcomes through timely and appropriate intervention with PDE5 inhibitors.